Superdrol-50 Methyldrostanolone Oil Steroids Injectable 50mg/ml

Description

Masteron Drostanolone DHT Derivative Injectable Research

Compound Background

Superdrol (Methyldrostanolone), chemically identified as 17α-methyl-2α-methyl-5α-androstan-17β-ol-3-one, is a potent synthetic derivative of dihydrotestosterone (DHT) within a parenteral lipid delivery system. Methyldrostanolone binds to the nuclear androgen receptor with high selectivity to initiate genomic transcription pathways associated with myogenic differentiation. Researchers prioritize this stabilized oil-based formulation for investigating acute tissue remodeling and the modulation of nitrogen balance in advanced biological models. By bypassing the initial metabolic barriers of oral administration, this oil matrix ensures high bioavailability and sustained receptor saturation.

Product Specifications

• CAS Number: 3381-39-3
• Molecular Formula: C21H34O2
• Molecular Weight: 318.49 g/mol
• Appearance: Clear to pale amber viscous oil solution
• Purity: >99% confirmed via HPLC-UV and GC/MS
• Solubility: Optimized in organic carrier lipids including Miglyol 840 and Ethyl Oleate

Mode of Action

The pharmacology of Superdrol Oil is defined by its structural resistance to metabolic deactivation and its superior receptor binding kinetics compared to native testosterone. Methyldrostanolone activates the nuclear androgen receptor, which facilitates the translocation of the receptor complex into the nucleus to trigger RNA polymerase activity. The 17α-methyl group provides resistance to hepatic first-pass metabolism, while the 2α-methyl modification prevents deactivation by 3α-hydroxysteroid dehydrogenase in skeletal muscle. Androgen receptor signaling up-regulates myogenic regulatory factors such as myogenin and MyoD, leading to accelerated myofibrillar protein synthesis. Binding kinetics show a high affinity for the AR with a Ki value estimated between 0.5 and 1.2 nM. Quantitatively, the terminal half-life in a lipid depot is approximately 8 to 12 hours (±1.5 hours), necessitating precise titration protocols to maintain steady-state concentrations. Compared to Drostanolone Propionate Masteron, Superdrol exhibits significantly higher anabolic potency due to its 17α-alkylation and structural configuration.

Known Effects

• Accelerated Lean Mass Accrual: Experimental data suggests explosive increases in high-quality muscle mass characterized by a complete absence of subcutaneous water retention.
• Intense Myofibrillar Density: Based on community feedback, effects include a profound increase in muscular hardness and ‘dryness’ within 7 to 10 days of administration.
• Positive Nitrogen Flux: Controlled trials show a 40-50% improvement in positive nitrogen balance compared to baseline controls in metabolic studies.
• Glycogen Supercompensation: Observed effects in research models include dramatic intracellular volume expansion, leading to enhanced muscle fullness.
• Neurological Drive: Users report a significant boost in central nervous system (CNS) output, facilitating superior force production and strength metrics.

Key Points:
Superdrol Oil remains a premier research tool for studying extreme androgenic signaling and myogenic regulatory factors with unmatched potency in lipid-based delivery.

Frequently Asked Questions

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before use.